VisuFect-mediated siRNA delivery into zygotes

Area of Science:

• Biotechnology
• Molecular Biology
• Developmental Biology

Background:

• Mammalian cell genetic material delivery methods are effective but toxic and inefficient for oocytes and embryos.
• Existing methods often cause membrane damage during genetic material delivery.
• There is a need for safe and efficient methods for genetic material delivery in early embryonic systems.

Purpose of the Study:

• To develop and evaluate an organic compound (VisuFect)-mediated small interfering RNA (siRNA) delivery method for mammalian oocytes and embryos.
• To assess the efficiency and safety of VisuFect-mediated delivery in P19 cells and mouse zygotes.
• To demonstrate the functional impact of delivered siRNA on gene expression and embryonic development.

Main Methods:

• Development of an organic compound, VisuFect, for siRNA delivery.
• Conjugation of Oct4-siRNA with VisuFect (Oct4-siRNA-VF).
• Evaluation of Oct4-siRNA-VF delivery in P19 cells and mouse zygotes, assessing zona pellucida penetration, intracellular localization, membrane integrity, Oct4 gene expression, and embryonic development.

Main Results:

• VisuFect-mediated delivery of Oct4-siRNA-VF successfully permeated the zona pellucida of mouse zygotes.
• The compound localized intracellularly without causing membrane damage.
• Significant transcriptional repression of Oct4 expression was observed, leading to repressed embryonic development.

Conclusions:

• VisuFect provides a safe and effective method for siRNA delivery into mouse zygotes.
• This technique overcomes previous limitations in oocyte and embryo genetic manipulation.
• VisuFect-mediated gene silencing holds promise for studying gene function in early embryonic development.